Phase 2 Trials - Vaccines

Relevant Publications

A phase I, randomized, placebo-controlled trial to evaluate the pharmacokinetics, safety, and tolerability of nirsevimab in healthy Chinese adults.

Issue Release: 2025

Developing a knowledge transfer and exchange strategy for a clinical trials unit.

Issue Release: 2025

Metronomic Capecitabine Plus Aromatase Inhibitor as Initial Therapy in Patients With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer-The Phase III MECCA Trial.

Issue Release: 2025

Online Radiotherapy: The Paradigm Shift to Real-Time Adaptive Radiotherapy.

Issue Release: 2025

Evaluation of Safety and Efficacy of a Single Lorecivivint Injection in Patients with Knee Osteoarthritis: A Multicenter, Observational Extension Trial.

Issue Release: 2025

Results of a patient-level pooled analysis of three studies of trastuzumab deruxtecan in HER2-positive breast cancer with active brain metastasis.

Issue Release: 2025

The Impact of Dietary Encapsulated Fennel Seed (Foeniculum vulgare Mill.) Essential Oil Inclusion Levels on Performance, Serum Hormone Profiles, and Expression of Reproductive Axis-Related Genes in the Early and Late Laying Phases of Hens.

Issue Release: 2025

What participants are told about receiving trial results when they consent to participate in a trial.

Issue Release: 2025

Safety and immunogenicity of an acellular pertussis vaccine containing genetically detoxified pertussis toxin administered to pregnant women living with and without HIV and their newborns (WoMANPOWER): a randomised controlled trial in Uganda.

Issue Release: 2025

Brain radiotherapy combined with camrelizumab and platinum-doublet chemotherapy for previously untreated advanced non-small-cell lung cancer with brain metastases (C-Brain): a multicentre, single-arm, phase 2 trial.

Issue Release: 2025

Exclusion of people from oncology clinical trials based on functional status.

Issue Release: 2025

Proteomic changes upon treatment with semaglutide in individuals with obesity.

Issue Release: 2025

c-Myc-targeted therapy in breast cancer: A review of fundamentals and pharmacological Insights.

Issue Release: 2025

[Clinical efficacy of sublingual immunotherapy for allergic rhinitis].

Issue Release: 2025

[Pharmacological characteristics and clinical study results of ensitrelvir fumaric acid (XOCOVA Tablets 125 ‍mg)].

Issue Release: 2024

Innovative approaches to wound healing: insights into interactive dressings and future directions.

Issue Release: 2024

Rapid Development of a Registry to Accelerate COVID-19 Vaccine Clinical Trials.

Issue Release: 2024

Time-course of drug-related psychiatric and behavioral treatment-emergent adverse events during brivaracetam treatment in adults with focal-onset seizures.

Issue Release: 2024

A phase II study (AARDVARC) of AZD4635 in combination with durvalumab and cabazitaxel in patients with progressive, metastatic, castration-resistant prostate cancer.

Issue Release: 2024

Can placebo-controlled phase 2 disease-modifying therapy trials in MS still be justified?

Issue Release: 2024

What is Pharmacovigilance?

What Challenges Exist in Using Molecular Diagnostics for Vaccines?

Why is it Important?

How does the VSD ensure data privacy and security?

How Do Vaccines Activate T Cells?

What is Measles?

How is Dosage Determined?

What is Malaria?

How Effective are Polio Vaccines?

What are Clinical Trials?

Phase 2 Trials - Vaccines

Relevant Publications

Partnered Content Networks

Relevant Topics